Diabetes and weight loss treatments like Novo Nordisks Ozempic and Eli Lillys Mounjaro are bringing in billions of dollars in sales spurring a wave of wouldbe competitors. Meanwhile new kinds of autoimmune disease drugs are being looked to as successors to current blockbusters and complex cancer treatments like radiopharmaceuticals and antibodydrug conjugates are newly in vogue